OGEN Stock Summary and Trading Ideas (Oragenics | AMEX:OGEN)

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

Oragenics trades on the AMEX stock market under the symbol OGEN.

As of August 28, 2026, OGEN stock price declined to $0.52 with 21,215 million shares trading.

OGEN has a beta of 2.23, meaning it tends to be more sensitive to market movements. OGEN has a correlation of 0.17 to the broad based SPY ETF.

OGEN has a market cap of $2.37 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, OGEN traded as high as $232.20 and as low as $.48.

OGEN has underperformed the market in the last year with a price return of -53.1% while the SPY ETF gained +19.7%. OGEN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.6% and -1.6%, respectively, while the SPY returned +2.2% and -0.9%, respectively.

OGEN support price is $.51 and resistance is $.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OGEN shares will trade within this expected range on the day.